Key result
Indian coronary stent trials reveal key limitations in trial design and patient population representation.
Why the study?
The burden of CAD has increased in the Indian population, including among young Indians, and this short communication presents the number of trials, patients involved, and limitations of coronary stent trials conducted in Indian CAD patients.
Key points are not available for this paper at this time.
Population
Indian coronary artery disease patients in coronary stent clinical trials
Design
Short communication
Answers are grounded in this paper and cite their sources.
Data on stents in Indian CAD patients remain limited; cautions against broad extrapolation and leaves open need for robust local trials.
The Coronary Artery Disease (CAD) burden increased in Indian population and even it is increasingin young Indians. There are more ways to treat these patients and coronary stents areone of the option for them. In the present short communication I am presenting the number oftrials, number of patients involved and the limitation of the trials conducted in Indian coronaryartery disease patients.
No takes yet. Share an insight, caveat, or question.
Srirangam Prashanth (2016) studied this question. Coronary stent clinical trials in Indian patients with coronary artery disease are summarized regarding trial numbers, patient populations, and study limitations.
Synapse has enriched 10 related papers. Consider them for comparative context: